[HTML][HTML] Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer

Y Hashiguchi, K Muro, Y Saito, Y Ito, Y Ajioka… - International journal of …, 2020 - Springer
The number of deaths from colorectal cancer in Japan continues to increase. Colorectal
cancer deaths exceeded 50,000 in 2016. In the 2019 edition, revision of all aspects of …

Recent updates in the surgical treatment of colorectal cancer

T Matsuda, K Yamashita, H Hasegawa… - Annals of …, 2018 - Wiley Online Library
Because of recent advances in medical technology and new findings of clinical trials,
treatment options for colorectal cancer are evolutionally changing, even in the last few years …

[HTML][HTML] Mesorectal excision with or without lateral lymph node dissection for clinical stage II/III lower rectal cancer (JCOG0212): a multicenter, randomized controlled …

S Fujita, J Mizusawa, Y Kanemitsu, M Ito… - Annals of …, 2017 - journals.lww.com
Objective: The aim of the study was to confirm the noninferiority of mesorectal excision (ME)
alone to ME with lateral lymph node dissection (LLND) in terms of efficacy. Background …

[HTML][HTML] Lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer: a single-center experience and literature review

MC Kim, JH Oh - Annals of Coloproctology, 2021 - ncbi.nlm.nih.gov
Purpose We aimed to evaluate the surgicopathological outcomes of lateral pelvic lymph
node dissection (LPLD) and long-term oncological outcomes of selective LPLD after …

Who should get lateral pelvic lymph node dissection after neoadjuvant chemoradiation?

S Malakorn, Y Yang, BK Bednarski… - Diseases of the Colon …, 2019 - journals.lww.com
BACKGROUND: Despite the use of neoadjuvant chemoradiation and total mesorectal
excision for rectal cancer, lateral pelvic lymph node recurrence is still an important problem …

[HTML][HTML] Radiomics approach outperforms diameter criteria for predicting pathological lateral lymph node metastasis after neoadjuvant (chemo) radiotherapy in …

R Nakanishi, T Akiyoshi, S Toda, Y Murakami… - Annals of surgical …, 2020 - Springer
Background Advanced low rectal cancer has a non-negligible risk of lateral pelvic lymph
node (LPLN) metastasis (LPLNM) and lateral local recurrence (LR) after neoadjuvant …

Optimal size criteria for lateral lymph node dissection after neoadjuvant chemoradiotherapy for rectal cancer

K Kawai, H Shiratori, K Hata, H Nozawa… - Diseases of the Colon …, 2021 - journals.lww.com
BACKGROUND: Although chemoradiotherapy followed by radical surgery without lateral
lymph node dissection is the current standard treatment in patients with rectal cancer, recent …

Feasibility of laparoscopic total mesorectal excision with extended lateral pelvic lymph node dissection for advanced lower rectal cancer after preoperative …

A Ogura, T Akiyoshi, T Nagasaki, T Konishi… - World journal of …, 2017 - Springer
Background The feasibility of additional lateral pelvic lymph node dissection (LPLND)
compared with total mesorectal excision (TME) alone in patients treated with preoperative …

[HTML][HTML] Outcomes and prognostic factors of selective lateral pelvic lymph node dissection with preoperative chemoradiotherapy for locally advanced rectal cancer

T Matsuda, Y Sumi, K Yamashita, H Hasegawa… - International journal of …, 2018 - Springer
Purpose The clinical significance of preoperative chemoradiotherapy (CRT) and lateral
lymph node dissection (LLND) for locally advanced rectal cancer remains unclear. We have …

[HTML][HTML] Optimal treatment strategies for clinically suspicious lateral pelvic lymph node metastasis in rectal cancer

HJ Kim, GS Choi, JS Park, SY Park, SH Cho, SJ Lee… - Oncotarget, 2017 - ncbi.nlm.nih.gov
Background Although lateral pelvic lymph node (LPN) metastasis is a major cause of local
recurrence in patients with rectal cancer, controversy still remains on the treatment of …